Business
Citius Pharmaceuticals, Inc. Announces Appointment of Ilanit Allen as Vice President, Corporate Communications and Investor Relations
Citius Pharmaceuticals Expands Management Team to Support Anticipated Milestones and Business Growth CRANFORD, N.J., May 17, 2021 /PRNewswire/ -- Citius
About this update from Citius Pharmaceuticals, Inc.
[{"type":"text","content":"Citius Pharmaceuticals Expands Management Team to Support Anticipated Milestones and Business Growth\n\n\nCRANFORD, N.J., May 17, 2021 /PRNewswire/ -- Citius Pharmaceuticals, Inc. (\"Citius\" or the \"Company\") (Nasdaq: CTXR) today announced that Ilanit Allen has been appointed Vice President of Corporate Communications and Investor Relations, effective immediately. In this newly created role, Ms. Allen will spearhead financial communication and investor activities, reporting to Myron Holubiak, President and Chief Executive Officer of Citius.\n\"We are thrilled to welcome Ilanit to the Citius team as we advance our pipeline of first-in-class critical care products,\" stated Mr. Holubiak. \"I am confident that Ilanit's extensive communications and investor relations experience, coupled with her financial and strategic mindset, will be an invaluable resource for our investors and the broader financial community. With multiple expected milestones on the horizon, we look forward to leveraging Ilanit's expertise in communicating the Citius story with our stakeholders.\" \n\"The Citius leadership team has a distinguished track record of successfully bringing important pharmaceutical products to market. I look forward to engaging with the investment community to share the Company's growth strategy and value-drivers, as management continues to position Citius to deliver long-term growth for shareholders,\" stated Ms. Allen. \nMs. Allen joins Citius with more than 20 years of experience in corporate communications, investor relations, strategy and investment banking. Since 2014, Ms. Allen has provided investor relations counsel to more than two dozen private and public life science companies. Previously, she advised executives across a broad spectrum of industries and growth stages, including technology startups and Fortune 500 financial institutions. Ilanit began her career as an investment banking analyst at SG Cowen with a focus on mergers and acquisitions. Ms. Allen holds an MBA from Harvard Business School, a Bachelor of Science degree in Finance from The Wharton School, and a Bachelor of Arts degree in International Relations from the University of Pennsylvania. \nAndrew Scott, Vice President of Special Projects, will assume greater responsibility for business development activities and will remain a resource for the investment co...